Echography Study_Anthropometric Measurements
Not Applicable
Recruiting
- Conditions
- Healthy Subjects
- Interventions
- Other: Ultrasound scans
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2024-07-22
- Lead Sponsor
- Crossject
- Target Recruit Count
- 90
- Registration Number
- NCT06279689
- Locations
- 🇺🇸
Clinical Trials of Texas, LLC dba Flourish Research, San Antonio, Texas, United States
Evaluation by Magnetic Resonance Imaging of Intramuscular Injections Performance in Thigh With 2 Configurations of the Needle-free Injector ZENEO®.
Not Applicable
Completed
- Conditions
- Needle-free Injector
- Interventions
- Combination Product: Injections in thigh of 0.625 mL of physiological serum with ZENEO® injector, on bare skin and through clothing.
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2024-04-01
- Lead Sponsor
- Crossject
- Target Recruit Count
- 63
- Registration Number
- NCT05967013
- Locations
- 🇫🇷
CHU DIJON Bourgogne - Hôpital François Mitterrand, Dijon, France
Bioavailability Study of Midazolam Administered as a Solution by Conventional Syringe or ZENEO®
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Combination Product: ZENEO® Midazolam (10 mg/0.625 mL) on bare skin in thighCombination Product: ZENEO® Midazolam (10 mg / 0.625 mL) through clothing in thighCombination Product: ZENEO® Midazolam (10 mg / 0.625 mL) on bare skin in ventrogluteal area
- First Posted Date
- 2021-08-30
- Last Posted Date
- 2022-07-22
- Lead Sponsor
- Crossject
- Target Recruit Count
- 40
- Registration Number
- NCT05026567
- Locations
- 🇿🇦
FARMOVS Pty Ltd, Bloemfontein, South Africa
Performance Evaluation by Magnetic Resonance Imaging (MRI) of Intramuscular Thigh Injections With 3 Configurations of Needle-free Injector (ZENEO®)
Not Applicable
- Conditions
- No Condition
- Interventions
- Combination Product: Intramuscular ZENEO® injection of nominal strengthCombination Product: Intramuscular ZENEO® injection of low strength (lower limit)Combination Product: Intramuscular ZENEO® injection of low strength (upper limit)
- First Posted Date
- 2017-07-21
- Last Posted Date
- 2017-07-21
- Lead Sponsor
- Crossject
- Target Recruit Count
- 86
- Registration Number
- NCT03225638
A Bioavailability Study of Methotrexate 25 mg Administered by Needle Injection and a Pre Filled Needle-free Device in Healthy Volunteers.
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Other: Zeneo® - Methotrexate
- First Posted Date
- 2017-04-06
- Last Posted Date
- 2021-02-16
- Lead Sponsor
- Crossject
- Target Recruit Count
- 58
- Registration Number
- NCT03103334
Performance Thresholds Evaluation by Wet Injection Quantification and Magnetic Resonance Imaging (MRI) of Subcutaneous and Intramuscular Injections (0,65ml) of Several Configurations of Needle-free Devices (ZENEO®)
Not Applicable
Completed
- Conditions
- No Condition
- Interventions
- Combination Product: Subcutaneous low ZENEO® injectionCombination Product: Intramuscular ZENEO® injectionCombination Product: Subcutaneous high ZENEO® injection
- First Posted Date
- 2017-02-07
- Last Posted Date
- 2017-02-07
- Lead Sponsor
- Crossject
- Target Recruit Count
- 97
- Registration Number
- NCT03044301
© Copyright 2025. All Rights Reserved by MedPath